Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Antidiabetic (OAD) Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Sulphonylureas
1.2.3 Biguanides
1.2.4 Intestinal α-Glucosidase Inhibitors
1.2.5 Others
1.3 Market by Application
1.3.1 Global Oral Antidiabetic (OAD) Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Diabetics Treatment Centres
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oral Antidiabetic (OAD) Treatment Market Perspective (2018-2033)
2.2 Oral Antidiabetic (OAD) Treatment Growth Trends by Region
2.2.1 Global Oral Antidiabetic (OAD) Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Oral Antidiabetic (OAD) Treatment Historic Market Size by Region (2018-2023)
2.2.3 Oral Antidiabetic (OAD) Treatment Forecasted Market Size by Region (2024-2033)
2.3 Oral Antidiabetic (OAD) Treatment Market Dynamics
2.3.1 Oral Antidiabetic (OAD) Treatment Industry Trends
2.3.2 Oral Antidiabetic (OAD) Treatment Market Drivers
2.3.3 Oral Antidiabetic (OAD) Treatment Market Challenges
2.3.4 Oral Antidiabetic (OAD) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral Antidiabetic (OAD) Treatment Players by Revenue
3.1.1 Global Top Oral Antidiabetic (OAD) Treatment Players by Revenue (2018-2023)
3.1.2 Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Oral Antidiabetic (OAD) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oral Antidiabetic (OAD) Treatment Revenue
3.4 Global Oral Antidiabetic (OAD) Treatment Market Concentration Ratio
3.4.1 Global Oral Antidiabetic (OAD) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Antidiabetic (OAD) Treatment Revenue in 2022
3.5 Oral Antidiabetic (OAD) Treatment Key Players Head office and Area Served
3.6 Key Players Oral Antidiabetic (OAD) Treatment Product Solution and Service
3.7 Date of Enter into Oral Antidiabetic (OAD) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Antidiabetic (OAD) Treatment Breakdown Data by Type
4.1 Global Oral Antidiabetic (OAD) Treatment Historic Market Size by Type (2018-2023)
4.2 Global Oral Antidiabetic (OAD) Treatment Forecasted Market Size by Type (2024-2033)
5 Oral Antidiabetic (OAD) Treatment Breakdown Data by Application
5.1 Global Oral Antidiabetic (OAD) Treatment Historic Market Size by Application (2018-2023)
5.2 Global Oral Antidiabetic (OAD) Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Oral Antidiabetic (OAD) Treatment Market Size (2018-2033)
6.2 North America Oral Antidiabetic (OAD) Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Oral Antidiabetic (OAD) Treatment Market Size by Country (2018-2023)
6.4 North America Oral Antidiabetic (OAD) Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oral Antidiabetic (OAD) Treatment Market Size (2018-2033)
7.2 Europe Oral Antidiabetic (OAD) Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Oral Antidiabetic (OAD) Treatment Market Size by Country (2018-2023)
7.4 Europe Oral Antidiabetic (OAD) Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size (2018-2033)
8.2 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oral Antidiabetic (OAD) Treatment Market Size (2018-2033)
9.2 Latin America Oral Antidiabetic (OAD) Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Oral Antidiabetic (OAD) Treatment Market Size by Country (2018-2023)
9.4 Latin America Oral Antidiabetic (OAD) Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size (2018-2033)
10.2 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Oral Antidiabetic (OAD) Treatment Introduction
11.1.4 Pfizer Revenue in Oral Antidiabetic (OAD) Treatment Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Detail
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Oral Antidiabetic (OAD) Treatment Introduction
11.2.4 Eli Lilly Revenue in Oral Antidiabetic (OAD) Treatment Business (2018-2023)
11.2.5 Eli Lilly Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Oral Antidiabetic (OAD) Treatment Introduction
11.3.4 Merck Revenue in Oral Antidiabetic (OAD) Treatment Business (2018-2023)
11.3.5 Merck Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Oral Antidiabetic (OAD) Treatment Introduction
11.4.4 Sanofi Revenue in Oral Antidiabetic (OAD) Treatment Business (2018-2023)
11.4.5 Sanofi Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Detail
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Oral Antidiabetic (OAD) Treatment Introduction
11.5.4 AstraZeneca Revenue in Oral Antidiabetic (OAD) Treatment Business (2018-2023)
11.5.5 AstraZeneca Recent Development
11.6 Glenmark
11.6.1 Glenmark Company Detail
11.6.2 Glenmark Business Overview
11.6.3 Glenmark Oral Antidiabetic (OAD) Treatment Introduction
11.6.4 Glenmark Revenue in Oral Antidiabetic (OAD) Treatment Business (2018-2023)
11.6.5 Glenmark Recent Development
11.7 Novartis
11.7.1 Novartis Company Detail
11.7.2 Novartis Business Overview
11.7.3 Novartis Oral Antidiabetic (OAD) Treatment Introduction
11.7.4 Novartis Revenue in Oral Antidiabetic (OAD) Treatment Business (2018-2023)
11.7.5 Novartis Recent Development
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Detail
11.8.2 Boehringer Ingelheim Business Overview
11.8.3 Boehringer Ingelheim Oral Antidiabetic (OAD) Treatment Introduction
11.8.4 Boehringer Ingelheim Revenue in Oral Antidiabetic (OAD) Treatment Business (2018-2023)
11.8.5 Boehringer Ingelheim Recent Development
11.9 Novo Nordisk
11.9.1 Novo Nordisk Company Detail
11.9.2 Novo Nordisk Business Overview
11.9.3 Novo Nordisk Oral Antidiabetic (OAD) Treatment Introduction
11.9.4 Novo Nordisk Revenue in Oral Antidiabetic (OAD) Treatment Business (2018-2023)
11.9.5 Novo Nordisk Recent Development
11.10 Mannkind
11.10.1 Mannkind Company Detail
11.10.2 Mannkind Business Overview
11.10.3 Mannkind Oral Antidiabetic (OAD) Treatment Introduction
11.10.4 Mannkind Revenue in Oral Antidiabetic (OAD) Treatment Business (2018-2023)
11.10.5 Mannkind Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Oral Antidiabetic (OAD) Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Sulphonylureas
Table 3. Key Players of Biguanides
Table 4. Key Players of Intestinal α-Glucosidase Inhibitors
Table 5. Key Players of Others
Table 6. Global Oral Antidiabetic (OAD) Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Oral Antidiabetic (OAD) Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Oral Antidiabetic (OAD) Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Oral Antidiabetic (OAD) Treatment Market Share by Region (2018-2023)
Table 10. Global Oral Antidiabetic (OAD) Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Oral Antidiabetic (OAD) Treatment Market Share by Region (2024-2033)
Table 12. Oral Antidiabetic (OAD) Treatment Market Trends
Table 13. Oral Antidiabetic (OAD) Treatment Market Drivers
Table 14. Oral Antidiabetic (OAD) Treatment Market Challenges
Table 15. Oral Antidiabetic (OAD) Treatment Market Restraints
Table 16. Global Oral Antidiabetic (OAD) Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Oral Antidiabetic (OAD) Treatment Market Share by Players (2018-2023)
Table 18. Global Top Oral Antidiabetic (OAD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antidiabetic (OAD) Treatment as of 2022)
Table 19. Ranking of Global Top Oral Antidiabetic (OAD) Treatment Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Oral Antidiabetic (OAD) Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Oral Antidiabetic (OAD) Treatment Product Solution and Service
Table 23. Date of Enter into Oral Antidiabetic (OAD) Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Oral Antidiabetic (OAD) Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Type (2018-2023)
Table 27. Global Oral Antidiabetic (OAD) Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Type (2024-2033)
Table 29. Global Oral Antidiabetic (OAD) Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Application (2018-2023)
Table 31. Global Oral Antidiabetic (OAD) Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Application (2024-2033)
Table 33. North America Oral Antidiabetic (OAD) Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Oral Antidiabetic (OAD) Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Oral Antidiabetic (OAD) Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Oral Antidiabetic (OAD) Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Oral Antidiabetic (OAD) Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Oral Antidiabetic (OAD) Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Oral Antidiabetic (OAD) Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Oral Antidiabetic (OAD) Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Oral Antidiabetic (OAD) Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 48. Pfizer Company Detail
Table 49. Pfizer Business Overview
Table 50. Pfizer Oral Antidiabetic (OAD) Treatment Product
Table 51. Pfizer Revenue in Oral Antidiabetic (OAD) Treatment Business (2018-2023) & (US$ Million)
Table 52. Pfizer Recent Development
Table 53. Eli Lilly Company Detail
Table 54. Eli Lilly Business Overview
Table 55. Eli Lilly Oral Antidiabetic (OAD) Treatment Product
Table 56. Eli Lilly Revenue in Oral Antidiabetic (OAD) Treatment Business (2018-2023) & (US$ Million)
Table 57. Eli Lilly Recent Development
Table 58. Merck Company Detail
Table 59. Merck Business Overview
Table 60. Merck Oral Antidiabetic (OAD) Treatment Product
Table 61. Merck Revenue in Oral Antidiabetic (OAD) Treatment Business (2018-2023) & (US$ Million)
Table 62. Merck Recent Development
Table 63. Sanofi Company Detail
Table 64. Sanofi Business Overview
Table 65. Sanofi Oral Antidiabetic (OAD) Treatment Product
Table 66. Sanofi Revenue in Oral Antidiabetic (OAD) Treatment Business (2018-2023) & (US$ Million)
Table 67. Sanofi Recent Development
Table 68. AstraZeneca Company Detail
Table 69. AstraZeneca Business Overview
Table 70. AstraZeneca Oral Antidiabetic (OAD) Treatment Product
Table 71. AstraZeneca Revenue in Oral Antidiabetic (OAD) Treatment Business (2018-2023) & (US$ Million)
Table 72. AstraZeneca Recent Development
Table 73. Glenmark Company Detail
Table 74. Glenmark Business Overview
Table 75. Glenmark Oral Antidiabetic (OAD) Treatment Product
Table 76. Glenmark Revenue in Oral Antidiabetic (OAD) Treatment Business (2018-2023) & (US$ Million)
Table 77. Glenmark Recent Development
Table 78. Novartis Company Detail
Table 79. Novartis Business Overview
Table 80. Novartis Oral Antidiabetic (OAD) Treatment Product
Table 81. Novartis Revenue in Oral Antidiabetic (OAD) Treatment Business (2018-2023) & (US$ Million)
Table 82. Novartis Recent Development
Table 83. Boehringer Ingelheim Company Detail
Table 84. Boehringer Ingelheim Business Overview
Table 85. Boehringer Ingelheim Oral Antidiabetic (OAD) Treatment Product
Table 86. Boehringer Ingelheim Revenue in Oral Antidiabetic (OAD) Treatment Business (2018-2023) & (US$ Million)
Table 87. Boehringer Ingelheim Recent Development
Table 88. Novo Nordisk Company Detail
Table 89. Novo Nordisk Business Overview
Table 90. Novo Nordisk Oral Antidiabetic (OAD) Treatment Product
Table 91. Novo Nordisk Revenue in Oral Antidiabetic (OAD) Treatment Business (2018-2023) & (US$ Million)
Table 92. Novo Nordisk Recent Development
Table 93. Mannkind Company Detail
Table 94. Mannkind Business Overview
Table 95. Mannkind Oral Antidiabetic (OAD) Treatment Product
Table 96. Mannkind Revenue in Oral Antidiabetic (OAD) Treatment Business (2018-2023) & (US$ Million)
Table 97. Mannkind Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oral Antidiabetic (OAD) Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Oral Antidiabetic (OAD) Treatment Market Share by Type: 2022 VS 2033
Figure 3. Sulphonylureas Features
Figure 4. Biguanides Features
Figure 5. Intestinal α-Glucosidase Inhibitors Features
Figure 6. Others Features
Figure 7. Global Oral Antidiabetic (OAD) Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Oral Antidiabetic (OAD) Treatment Market Share by Application: 2022 VS 2033
Figure 9. Hospital Case Studies
Figure 10. Clinics Case Studies
Figure 11. Diabetics Treatment Centres Case Studies
Figure 12. Others Case Studies
Figure 13. Oral Antidiabetic (OAD) Treatment Report Years Considered
Figure 14. Global Oral Antidiabetic (OAD) Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Oral Antidiabetic (OAD) Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Oral Antidiabetic (OAD) Treatment Market Share by Region: 2022 VS 2033
Figure 17. Global Oral Antidiabetic (OAD) Treatment Market Share by Players in 2022
Figure 18. Global Top Oral Antidiabetic (OAD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antidiabetic (OAD) Treatment as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Oral Antidiabetic (OAD) Treatment Revenue in 2022
Figure 20. North America Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Oral Antidiabetic (OAD) Treatment Market Share by Country (2018-2033)
Figure 22. United States Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Oral Antidiabetic (OAD) Treatment Market Share by Country (2018-2033)
Figure 26. Germany Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Share by Region (2018-2033)
Figure 34. China Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Oral Antidiabetic (OAD) Treatment Market Share by Country (2018-2033)
Figure 42. Mexico Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Share by Country (2018-2033)
Figure 46. Turkey Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Pfizer Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2018-2023)
Figure 49. Eli Lilly Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2018-2023)
Figure 50. Merck Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2018-2023)
Figure 51. Sanofi Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2018-2023)
Figure 52. AstraZeneca Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2018-2023)
Figure 53. Glenmark Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2018-2023)
Figure 54. Novartis Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2018-2023)
Figure 55. Boehringer Ingelheim Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2018-2023)
Figure 56. Novo Nordisk Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2018-2023)
Figure 57. Mannkind Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed